0001127602-20-010315.txt : 20200311 0001127602-20-010315.hdr.sgml : 20200311 20200311205001 ACCESSION NUMBER: 0001127602-20-010315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200310 FILED AS OF DATE: 20200311 DATE AS OF CHANGE: 20200311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VON ESCHENBACH ANDREW C. CENTRAL INDEX KEY: 0001536529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 20706972 MAIL ADDRESS: STREET 1: 163 SARASOTA CIRCLE SOUTH CITY: MONTGOMERY STATE: TX ZIP: 77356 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-03-10 0000885590 Bausch Health Companies Inc. BHC 0001536529 VON ESCHENBACH ANDREW C. 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 Common Shares, No Par Value 2020-03-10 4 P 0 1100 18.1785 A 18565 D /s/ Kirsten O'Donnell, attorney-in-fact for Andrew C. von Eschenbach 2020-03-11